Cellebrite DI Ltd. (CLBT)

Full history for every metric is available with a Kvantra account

Stock profile
Cellebrite DI Ltd. logo

Cellebrite DI Ltd. (CLBT)

Country: IsraelSector: TechnologyIndustry: Software - InfrastructureExchange: NASDAQ
P/E TTM
37.6
History
P/E NTM
39.1
Market cap
2.69B
Currency USD
KvantraRankAbout64
IValue63
IIQuality96
IIIMomentum23
Current price
10.79 USD-5.10%
Benchmarks

No price history available.

Key financial summary

Financials in USD
202020212022202320242025TTM2026E
Total revenue$m195246271325401476514557
Operating profit$m6657
Net profit$m671121-81-283785969
EPS reported$0.310.23
Operating cashflow per share$0.680.62
Capex per share$0.050.05
FCF per share$0.620.56
Free cash flow$m156140
Net debt$m-437-419
Book value equity$m484538
Book value per share$1.942.13
Number of sharesm249.9252.79
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
202020212022202320242025TTM2026E
Value
P/E TTMx58.1637.61
P/B LTMx9.308.37
P/S LTMx9.478.76
P/FCF LTMx28.9332.28
EV/EBITDA LTMx42.7338.75
EV/Sales LTMx9.265.32
Earnings Yield LTM%+1.72%+2.66%
FCF Yield%+3.46%+3.10%
Quality
ROE%+16.17%+11.87%
ROIC%+10.02%+6.93%
Operating margin%+13.98%+10.99%
Gross margin%+84.20%+82.96%
FCF/Sales%+32.74%+27.14%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+18.56%+28.19%
Net Income Growth YoY%--
FCF Growth%+28.11%+14.83%
Operating Profit Growth%+16.82%-0.64%
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%--
Payout Ratio%0.00%0.00%
FCF/Debtx6.876.01
Net Debt/EBITDAx-0.99-1.04
EBIT/Net interestx0.000.00
Net debt/market cap%0.00%+0.20%
Net debt/Equityx-0.90-0.78
Gross debt/equityx0.050.04

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price10.79 USD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, interpret, and oversee digital information throughout the investigative process. These essential tools are utilized in a wide array of scenarios, including cases involving child exploitation, homicides, counter-terrorism operations, border control, sexual offenses, human trafficking, corporate security incidents, intellectual property theft, and civil litigation. A key offering, the Universal Forensic Extraction Device (UFED), is engineered to surmount significant hurdles in accessing digital evidence, such as intricate device locks, encryption barriers, deleted data, and obscure content that might otherwise conceal crucial information. The company also provides Seeker, designed for analyzing video footage; OSINT Analyze, a real-time deep-dive tool for examining open-source information across the surface, deep, and dark web; and Crypto Tracer, which deciphers blockchain transactions alongside related data from numerous sources to identify and categorize digital wallets and activities. Cellebrite's clientele includes federal, state, and local government bodies, as well as various enterprise companies and service providers. Established in 1999 and headquartered in Petah Tikva, Israel, the firm operates internationally with a footprint in countries such as the United States, Germany, Singapore, Australia, Brazil, the United Kingdom, France, Canada, Japan, and India. Additionally, Cellebrite Mobile Synchronization Ltd. functions as a subsidiary of Sun Corporation.

SectorTechnology
IndustrySoftware - Infrastructure
CountryIsrael
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Cellebrite DI Ltd. (CLBT)

CLBT · NASDAQ · Technology
10.79 USD-5.10%
Sign up to track this stock

No price history available.

KvantraRank64
Market cap2.69B
P/E NTM39.1
P/E TTM37.6
KvantraRank?64 / 100
Value
63
Quality
96
Momentum
23
Financialsin USD
20242025TTM2026E
Analyst target
Consensus
Current10.79 USD
Upside
Price consensus
Last year average price target
Current price10.79 USD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, interpret, and oversee digital information throughout the investigative process. These essential tools are utilized in a wide array of scenarios, including cases involving child exploitation, homicides, counter-terrorism operations, border control, sexual offenses, human trafficking, corporate security incidents, intellectual property theft, and civil litigation. A key offering, the Universal Forensic Extraction Device (UFED), is engineered to surmount significant hurdles in accessing digital evidence, such as intricate device locks, encryption barriers, deleted data, and obscure content that might otherwise conceal crucial information. The company also provides Seeker, designed for analyzing video footage; OSINT Analyze, a real-time deep-dive tool for examining open-source information across the surface, deep, and dark web; and Crypto Tracer, which deciphers blockchain transactions alongside related data from numerous sources to identify and categorize digital wallets and activities. Cellebrite's clientele includes federal, state, and local government bodies, as well as various enterprise companies and service providers. Established in 1999 and headquartered in Petah Tikva, Israel, the firm operates internationally with a footprint in countries such as the United States, Germany, Singapore, Australia, Brazil, the United Kingdom, France, Canada, Japan, and India. Additionally, Cellebrite Mobile Synchronization Ltd. functions as a subsidiary of Sun Corporation.

SectorTechnology
IndustrySoftware - Infrastructure
CountryIsrael
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free